4300 Results for "

16

" in MedChemExpress (MCE) Product Catalog:
Products (4300)

4300 Results for "16" in MCE Product Catalog:

259
259 Publications Verification
Art. -Nr.: HY-50767
CAS. Nr.: 571190-30-2
Synonyms: PD 0332991
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
259
259 Publications Verification
Art. -Nr.: HY-50767A
CAS. Nr.: 827022-32-2
Synonyms: PD 0332991 monohydrochloride
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
255
255 Cited Publications
Art. -Nr.: HY-A0065
CAS. Nr.: 827022-33-3
Synonyms: PD 0332991 isethionate
Target:  

CDK

Forschungsgebiete:  

Infection Neurological Disease Cancer

Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
239
239 Cited Publications
Art. -Nr.: HY-50767C
CAS. Nr.: 571189-11-2
Synonyms: PD-0332991 hydrochloride
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) hydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib hydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells. Palbociclib hydrochloride can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
191
191 Cited Publications
Art. -Nr.: HY-13629
CAS. Nr.: 33419-42-0
Reinheit:  99.94%
Synonyms: VP-16; VP-16-213
Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .
loading...
    loading...
184
184 Cited Publications
Art. -Nr.: HY-10181A
CAS. Nr.: 854001-07-3
Reinheit:  98.86%
Synonyms: BMS-354825 hydrochloride
Forschungsgebiete:  

Cancer

Dasatinib (BMS-354825) hydrochloride is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib hydrochloride inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib hydrochloride also induces apoptosis and autophagy.
loading...
    loading...
184
184 Cited Publications
Art. -Nr.: HY-10181B
CAS. Nr.: 863127-77-9
Reinheit:  99.58%
Synonyms: BMS-354825 monohydrate
Forschungsgebiete:  

Cancer

Dasatinib (BMS-354825) monohydrate is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib monohydrate inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib monohydrate also induces apoptosis and autophagy.
loading...
    loading...
184
184 Cited Publications
Art. -Nr.: HY-10181
CAS. Nr.: 302962-49-8
Reinheit:  99.83%
Synonyms: BMS-354825
Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively. Dasatinib also induces apoptosis and autophagy, and can cross the blood-brain barrier .
loading...
    loading...
117
117 Cited Publications
Art. -Nr.: HY-134836
CAS. Nr.: 2499663-01-1
Reinheit:  99.86%
Target:  

Apoptosis METTL3

Forschungsgebiete:  

Cancer

STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be used for the research of acute myeloid leukaemia (AML) .
loading...
    loading...
106
106 Cited Publications
Art. -Nr.: HY-13605A
CAS. Nr.: 69-74-9
Reinheit:  99.67%
Synonyms: Cytosine β-D-arabinofuranoside hydrochloride; Cytosine Arabinoside hydrochloride; Ara-C hydrochloride
Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV.
loading...
    loading...
106
106 Cited Publications
Art. -Nr.: HY-13605
CAS. Nr.: 147-94-4
Reinheit:  99.98%
Synonyms: Cytosine β-D-arabinofuranoside; Cytosine Arabinoside; Ara-C
Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity.
loading...
    loading...
100
100 Cited Publications
Art. -Nr.: HY-13803
CAS. Nr.: 1403254-99-8
Reinheit:  99.93%
Synonyms: EPZ-6438; E-7438
Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat also inhibits EZH1 with an IC50 of 392 nM. Tazemetostat induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells .
loading...
    loading...
95
95 Cited Publications
Art. -Nr.: HY-12750
CAS. Nr.: 1448671-31-5
Reinheit:  99.93%
Forschungsgebiete:  

Cancer

AZD3965 is a selective MCT1 inhibitor with a Ki of 1.6 nM, showing 6-fold selectivity over MCT2.
loading...
    loading...
74
74 Cited Publications
Art. -Nr.: HY-N0822
CAS. Nr.: 517-89-5
Synonyms: C.I. 75535; Isoarnebin 4
Shikonin is a major component of a Chinese herbal medicine named zicao. Shikonin is a potent TMEM16A chloride channel inhibitor with an IC50 of 6.5 μM . Shikonin is a specific pyruvate kinase M2 (PKM2) inhibitor and can also inhibit TNF-α and NF-κB pathway . Shikonin decreases exosome secretion through the inhibition of glycolysis . Shikonin inhibits AIM2 inflammasome activation .
loading...
    loading...
65
65 Cited Publications
Art. -Nr.: HY-10532
CAS. Nr.: 925434-55-5
Reinheit:  99.90%
Target:  

Sirtuin Autophagy

Forschungsgebiete:  

Metabolic Disease

SRT 1720 is a selective activator of human SIRT1 with an EC1.5 of 0.16 μM, and shows less potent activities for SIRT2 and SIRT3 with EC1.5s of 37 μM and > 300 μM, respectively.
loading...
    loading...
64
64 Cited Publications
Art. -Nr.: HY-12683
CAS. Nr.: 314045-39-1
Reinheit:  98.07%
Target:  

Glutaminase

Forschungsgebiete:  

Cancer

BPTES is an allosteric and selective glutaminase inhibitor with an IC50 of 0.16 μM.
loading...
    loading...
45
45 Cited Publications
Art. -Nr.: HY-10065
CAS. Nr.: 319460-85-0
Reinheit:  99.90%
Synonyms: AG-013736
Target:  

VEGFR PDGFR

Forschungsgebiete:  

Cancer

Axitinib is a multi-targeted tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.6 nM for VEGFR1, VEGFR2, VEGFR3 and PDGFRβ, respectively.
loading...
    loading...
45
45 Cited Publications
Art. -Nr.: HY-13867
CAS. Nr.: 133052-90-1
Reinheit:  98.15%
Synonyms: GF109203X; Go 6850
Target:  

PKC GSK-3

Forschungsgebiete:  

Metabolic Disease Cancer

Bisindolylmaleimide I (GF109203X) is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I is also a GSK-3 inhibitor .
loading...
    loading...
45
45 Cited Publications
Art. -Nr.: HY-13867A
CAS. Nr.: 176504-36-2
Reinheit:  99.18%
Synonyms: GF109203X hydrochloride; Go 6850 hydrochloride
Target:  

PKC GSK-3

Forschungsgebiete:  

Metabolic Disease Cancer

Bisindolylmaleimide I (GF109203X) hydrochloride is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I hydrochloride is also a GSK-3 inhibitor .
loading...
    loading...
43
43 Cited Publications
Art. -Nr.: HY-108635
CAS. Nr.: 74389-68-7
Reinheit:  99.85%
Synonyms: PAF (C16)
C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability .
loading...
    loading...